**Core Concept**
The syndromic approach to managing sexually transmitted infections (STIs) is a clinical strategy that involves treating patients based on a set of symptoms or clinical findings, rather than waiting for laboratory confirmation. This approach is particularly useful in resource-limited settings where diagnostic facilities may not be readily available.

**Why the Correct Answer is Right**
The patient's presentation of vaginal discharge suggests a possible STI. Under the syndromic approach, the patient would be treated for pelvic inflammatory disease (PID), which is a common complication of STIs. Metronidazole is an antibiotic that is effective against the bacteria responsible for PID, including *Gardnerella vaginalis*, *Trichomonas vaginalis*, and anaerobic bacteria.

**Why Each Wrong Option is Incorrect**
**Option A:** Doxycycline is an antibiotic that is used to treat a variety of bacterial infections, including chlamydia and gonorrhea. However, it is not the first-line treatment for PID and would not be the preferred choice under the syndromic approach.

**Option B:** Fluconazole is an antifungal medication that is used to treat vaginal yeast infections, not STIs. This option is not relevant to the patient's presentation.

**Option C:** Clindamycin is an antibiotic that is used to treat a variety of bacterial infections, including PID. However, it is not the preferred choice under the syndromic approach and is often used in combination with other antibiotics.

**Option D:** Amoxicillin is an antibiotic that is used to treat a variety of bacterial infections, including PID. However, it is not the preferred choice under the syndromic approach and may not be effective against all the bacteria responsible for PID.

**Clinical Pearl / High-Yield Fact**
When using the syndromic approach to managing STIs, it is essential to remember that this approach is not a substitute for laboratory confirmation and follow-up testing. Patients should be re-evaluated and retreated if symptoms persist or recur.

**Correct Answer:** C. Clindamycin